Table 2.
Profile SCFA (Baseline, Interval, Endline)
| Characteristic SCFA titer (mM) | Placebo (n 21) | Probiotic (n 15) |
|---|---|---|
| Baseline-Acetate | 52.17 ± 45.38 | 53.93 ± 32.99 |
| Interval-Acetate | 80.17 ± 59.19 | 66.18 ± 51.20 |
| Endline-Acetate | 41.38 ± 38.23 | 81.51 ± 61.67 |
| Baseline-Propionate | 24.94 ± 23.50 | 21.85 ± 14.42 |
| Interval-Propionate | 38.06 ± 46.91 | 34.97 ± 29.76 |
| Endline-Propionate | 17.82 ± 21.29 | 41.60 ± 37.13 |
| Baseline-Butyrate | 43.29 ± 26.25 | 40.26 ± 20.62 |
| Interval-Butyrate | 39.04 ± 25.89 | 43.11 ± 25.61 |
| Endline Acetate | 41.38 ± 38.23 | 81.51 ± 61.67 |